By a GenomeWeb Staff Reporter
NEW YORK (GenomeWeb News) – Qiagen's acquisition strategy remains unchanged, and the firm is more likely to make smaller deals than any sort of big, transformative transaction, a company spokesperson told GenomeWeb Daily News today.
Registering provides access to this and other free content.
Already have an account?Login Now.
The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.
In Science this week: measles virus nucleocapsid structure, and more.
African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.
Nature has retracted a 2002 epigenetics paper for image manipulation.